CNSY

Cerenome, Inc

• TipRanks·10/02 11:58

  Cerenome Updates Investor Presentation on CNS Oncology Strategy

• Dow Jones·10/01 16:16

  Cerenome Is Maintained at Buy by Lake Street

• Dow Jones·10/01 16:16

  Cerenome Price Target Cut to $31.00/Share From $50.00 by Lake Street

• Benzinga·10/01 16:06

  Lake Street Maintains Buy on Cerenome, Lowers Price Target to $31

• TipRanks·10/01 12:40

  Cerenome price target lowered to $31 from $50 at Lake Street

• Benzinga·09/30 11:33

  Cerenome Anticipates $1.55M In Payer Billings In Q3

• NASDAQ·09/25 18:41

  5 Biotech Stocks Making Headlines - ADRX, CNSY, JAGX, AGL, ONCO

• NASDAQ·09/22 15:18

  Cerenome Expands CNSide Coverage Through Blue Cross Blue Shield Michigan Deal; Stock Up

• Dow Jones·09/16 11:30

  Press Release: Cerenome Appoints Samantha Fowlkes as Vice President and Head of Commercial Sales, CNSide Diagnostics Division

• Benzinga·09/11 12:21

  ServiceNow To Rally More Than 18%? Here Are 10 Top Analyst Forecasts For Friday

• Dow Jones·09/11 10:11

  Cerenome Price Target Cut to $43.00/Share From $57.00 by Ascendiant Capital

• Dow Jones·09/11 10:11

  Cerenome Is Maintained at Buy by Ascendiant Capital

• Benzinga·09/11 10:01

  Ascendiant Capital Maintains Buy on Cerenome, Lowers Price Target to $43

• TipRanks·09/10 12:30

  Cerenome Secures New Senior Financing to Extend Runway

• Benzinga·09/10 11:18

  Cerenome Enters Into Financing Agreement With 3i LP For Senior Secured Facility Of Up To $20M With Royalty-Based Repayments